Ohio Surgeon Performed New Thumb Arthritis Procedure

A new cup and stem implant system allows for faster recovery for thumb carpometacarpal arthritis patients.

Updated on Sept. 25, 2026 in Arthritis

Ohio Surgeon Performed New Thumb Arthritis Procedure

Live Poll

Do you trust new medical procedures to improve your personal quality of life?

In July 2026, Dr. Stephen Berling performed a thumb carpometacarpal arthritis procedure in Ohio using a newly approved implant system. The surgery utilizes a cup and stem design to provide stability and motion for patients.

Why it matters

This procedure offers a significant reduction in recovery time compared to traditional surgical methods for thumb arthritis. The implant system was granted FDA approval in 2025, bringing a treatment already used in Europe for a decade to U.S. patients.

The surgical procedure lasts approximately 45 minutes and does not require an overnight hospital stay. Recovery time is reduced to 6-9 weeks, significantly shorter than the 6-9 months required by traditional arthritis procedures.

The players

Dr. Stephen Berling

Dr. Stephen Berling is the surgeon who performed the thumb carpometacarpal arthritis procedure in Ohio.

Julia Brown

Julia Brown is the patient who underwent the thumb implant procedure and is scheduled for a follow-up surgery.

The details

The procedure replaces bone with a cup and stem implant system to treat carpometacarpal arthritis. This design provides immediate stability and restored motion for the thumb following the operation.

The procedure has been performed in Europe for 10 years as of 2016.
The FDA approved the thumb implant procedure in 2025.
Dr. Stephen Berling performed the surgery on Julia Brown in July 2026.
Julia Brown is scheduled for a second thumb surgery in the fall of 2026.

Health Landscape

The introduction of this implant system reflects a broader shift toward minimally invasive orthopedic surgery that prioritizes rapid patient mobilization. The procedure's U.S. adoption follows the standards set by the FDA's 510(k) medical device clearance process for orthopedic implants.

Patients suffering from thumb arthritis may experience significantly shorter recovery periods with this new procedure compared to traditional surgery. Because the surgery does not require an overnight hospital stay, individuals can expect a more efficient path to restored joint motion.

The takeaway

This new implant technology highlights how established international medical practices can eventually transform standard care in the United States. Patients interested in this option should consult with an orthopedic specialist to determine if their specific condition qualifies for the procedure.